Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDH…

Overview of attention for article published in The Lancet Respiratory Medicine, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

Źródło: The Lancet., op. Mikołaj Kamiński Redaktor: Monika Stelmach | Data: 01.03.2021 Z badań, których wyniki opublikowano w „Th…

NEW YORK (Reuters Health) - Results of a phase-3b trial confirm and extend the efficacy of benralizumab for patients with…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.